CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data ...
Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...
Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) and it is also prescribed for specific inflammatory conditions that ...
Many lung cancer patients already have cardiovascular disease when they are diagnosed, which increases their risk of ...
Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...
A recent study from New York University has found that platelets, the tiny fragments in our blood that help with clotting, ...
Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...
Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...
The FDA has accepted for review the BLA for lerodalcibep to reduce LDL-C in patients with or high risk of ASCVD and primary hyperlipidemia.
In addition to substantial lifestyle changes, there may be additional help in reversing atherosclerosis, including statin ...
A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback